Hospitalization rates for pneumococcal pneumonia in adults 65 and older in Portugal — which had been increasing on average by 16% per year before pneumococcal conjugate vaccines became available — began to reverse once PCVs became available for infants. The reduction in the elderly, over expected rates, was greatest after the introduction of PCV13.
Full Citation:
Kislaya I, Rodrigues AP, Sousa-Uva M et al.. 2019. Indirect effect of 7-valent and 13-valent pneumococcal conjugate vaccines on pneumococcal pneumonia hospitalizations in elderly. PLoS One. 14(1).
Title of Article: Indirect effect of 7-valent and 13-valent pneumococcal conjugate vaccines on pneumococcal pneumonia hospitalizations in elderly
Author(s): Kislaya I, Rodrigues AP, Sousa-Uva M et al.
Publication Year: 2019
Publication Name: PLoS One
Publication Volume: 14(1)
Publication Source URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334925/pdf/pone.0209428.pdf
DOI (Digital Object Identifier): https://doi/org/10.1371/journal.pone.0209428
Topics: Health
Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia
Countries: Portugal
WHO Regions: Europe